Literature DB >> 22126581

Epidemiological distribution and incidence of different cancers in Kashmir valley--2002-2006.

Shiekh Gazalla Ayub1, Taha Ayub, Saquib Naveed Khan, Shabhat Rasool, Khursheed Alam Wani, Sanaullah Kuchay, Mohd Maqbool Lone, Khurshid Iqbal Andrabi.   

Abstract

There are no population-based data available on cancer pattern in Kashmir and our study is the first kind which represents the trend in cancer pattern in the valley. The source of our data were cancer patients registered in the Department of Radiation Oncology, Sheri-Kashmir Institute of Medical Sciences, Srinagar, and Department of Radiation Oncology, SMHS, Srinagar during the period Jan 2002 to Dec 2006. These are leading medical centres in the valley and draw most all of cancer patients from all over Kashmir for treatment. During the period a total of 6,943 cases were registered of which 4,345 were males and 2,598 were females. The age standardized incidence rates were 34.9 per 100,000 for males and 24.8 per 100,000 for females. Oesophagus was the leading site of cancer in both sexes (male ASR 11.2; female ASR 8.3) followed by lung (ASR 6.5), brain (ASR 2.2) and head and neck (ASR 2.2) in males and breast (ASR 5.2), skin (ASR 1.6) and rectum (ASR 0.95) in females. The incidence of cervical cancer in females and prostate cancer in males was lower in Kashmir as compared to other Indian registries. Overall cancer incidence was significantly lower and cancer patterns were markedly different in Kashmir. The observed cancer pattern indicates that awareness campaigns, life style and dietary habit changes, tobacco-control measures and early detection of breast cancer are very important for cancer control in this population.

Entities:  

Mesh:

Year:  2011        PMID: 22126581

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

Review 1.  Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness.

Authors:  I Mattheij; A M Pollock; P Brhlikova
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

2.  Nasopharyngeal Carcinoma: A 15 Year Study with Respect to Clinicodemography and Survival Analysis.

Authors:  Shaqul Qamar Wani; Talib Khan; Saiful Yamin Wani; Liza Rafiq Mir; Mohammad Maqbool Lone; Tariq Rasool Malik; Arshad Manzoor Najmi; Fir Afroz; Mohammad Ashraf Teli; Nazir Ahmad Khan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2016-09-19

3.  Potential risk of esophageal squamous cell carcinoma due to nucleotide excision repair XPA and XPC gene variants and their interaction among themselves and with environmental factors.

Authors:  Rumaisa Rafiq; Gulzar Ahmad Bhat; Mohd Maqbool Lone; Akbar Masood; Nazir Ahmad Dar
Journal:  Tumour Biol       Date:  2016-01-29

4.  Challenges in understanding the epidemiology of acquired brain injury in India.

Authors:  Suresh Kumar Kamalakannan; Aashrai S V Gudlavalleti; Venkata S Murthy Gudlavalleti; Shifalika Goenka; Hannah Kuper
Journal:  Ann Indian Acad Neurol       Date:  2015 Jan-Mar       Impact factor: 1.383

5.  Family history of cancer and the risk of squamous cell carcinoma of oesophagus: a case-control study in Kashmir, India.

Authors:  G A Bhat; I A Shah; R Rafiq; S Nabi; B Iqbal; M M Lone; F Islami; P Boffetta; N A Dar
Journal:  Br J Cancer       Date:  2015-06-30       Impact factor: 7.640

6.  Epidemiology of Cancers in Kashmir, India: An Analysis of Hospital Data.

Authors:  Mariya A Qurieshi; S M Salim Khan; Muneer A Masoodi; Uruj Qurieshi; Quratul Ain; Yasmeen Jan; Inaamul Haq; Sheikh Zahoor Ahmad
Journal:  Adv Prev Med       Date:  2016-07-05

7.  Central nervous system tumors: Spotlight on India.

Authors:  Anusheel Munshi
Journal:  South Asian J Cancer       Date:  2016 Jul-Sep

8.  Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.

Authors:  Mujeeb Zafar Banday; Aga Syed Sameer
Journal:  Biosci Rep       Date:  2019-05-10       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.